×
About 5,211 results

ALLMedicine™ Hyperkalemia Center

Research & Reviews  2,123 results

Impact of a pharmacist-based multidimensional intervention aimed at decreasing the risk...
https://doi.org/10.1016/j.ijcard.2020.12.081
International Journal of Cardiology; Gallo-Bernal S, Calixto CA et. al.

Jan 7th, 2021 - Hyperkalemia is a potentially life-threatening condition associated with the use of heart failure (HF) medications, which can lead to increased morbidity and mortality. Novel approaches for hyperkalemia prevention are needed, especially in limited...

Timing of renal replacement therapy initiation for acute kidney injury in critically il...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789484
Critical Care (London, England); Li X, Liu C et. al.

Jan 7th, 2021 - Acute kidney injury (AKI) is a common serious complication in critically ill patients. AKI occurs in up to 50% patients in intensive care unit (ICU), with poor clinical prognosis. Renal replacement therapy (RRT) has been widely used in critically ...

Ventricular tachycardia in an adolescent with severe diabetic ketoacidosis.
https://doi.org/10.1016/j.ajem.2020.12.029
The American Journal of Emergency Medicine; Bergmann KR, Whitcomb V

Dec 30th, 2020 - Diabetic ketoacidosis (DKA) occurs frequently among children and adolescents with type 1 diabetes. Although a number of complications may occur during episodes of DKA, significant cardiac arrhythmias are uncommon. We present the case of an adolesc...

Randomised controlled trial of a smartphone application-based dietary self-management p...
https://doi.org/10.1111/jocn.15627
Journal of Clinical Nursing; Pack S, Lee J

Dec 30th, 2020 - To develop a smartphone application-based dietary self-management program for hemodialysis patients and to examine its effects on biochemical indicators, self-efficacy, and quality of life. Lack of dietary management in hemodialysis patients can l...

see more →

Drugs  169 results see all →

Clinicaltrials.gov  2,571 results

Hydrochlorothiazide - hydrochlorothiazide capsule-Direct_Rx
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=90a0a64c-1c98-f27b-e053-2a95a90a8ca5

Jan 11th, 2021 - Hydrochlorothiazide capsules are indicated in the management of hypertension either as the sole therapeutic agent, or in combination with other antihypertensives. Unlike potassium sparing combination diuretic products, hydrochlorothiazide capsules...

Impact of a pharmacist-based multidimensional intervention aimed at decreasing the risk...
https://doi.org/10.1016/j.ijcard.2020.12.081
International Journal of Cardiology; Gallo-Bernal S, Calixto CA et. al.

Jan 7th, 2021 - Hyperkalemia is a potentially life-threatening condition associated with the use of heart failure (HF) medications, which can lead to increased morbidity and mortality. Novel approaches for hyperkalemia prevention are needed, especially in limited...

Timing of renal replacement therapy initiation for acute kidney injury in critically il...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789484
Critical Care (London, England); Li X, Liu C et. al.

Jan 7th, 2021 - Acute kidney injury (AKI) is a common serious complication in critically ill patients. AKI occurs in up to 50% patients in intensive care unit (ICU), with poor clinical prognosis. Renal replacement therapy (RRT) has been widely used in critically ...

Ventricular tachycardia in an adolescent with severe diabetic ketoacidosis.
https://doi.org/10.1016/j.ajem.2020.12.029
The American Journal of Emergency Medicine; Bergmann KR, Whitcomb V

Dec 30th, 2020 - Diabetic ketoacidosis (DKA) occurs frequently among children and adolescents with type 1 diabetes. Although a number of complications may occur during episodes of DKA, significant cardiac arrhythmias are uncommon. We present the case of an adolesc...

see more →

News  347 results

Dapagliflozin Halves Hyperkalemia in Some HF Patients
https://www.staging.medscape.com/viewarticle/940012

Oct 28th, 2020 - For patients with heart failure with reduced ejection fraction (HFrEF), the addition of dapagliflozin (Farxiga) to a mineralocorticoid receptor antagonist (MRA) halved the incidence of moderate to severe hyperkalemia, a prespecified analysis of DA...

Dapagliflozin Halves Hyperkalemia in Some HF Patients
https://www.medscape.com/viewarticle/940012

Oct 28th, 2020 - For patients with heart failure with reduced ejection fraction (HFrEF), the addition of dapagliflozin (Farxiga) to a mineralocorticoid receptor antagonist (MRA) halved the incidence of moderate to severe hyperkalemia, a prespecified analysis of DA...

Novel Drug Slows Progression of Diabetic Kidney Disease
https://www.staging.medscape.com/viewarticle/939724

Oct 22nd, 2020 - For patients with diabetic kidney disease, finerenone, an agent from a new class of selective, nonsteroidal mineralocorticoid receptor antagonists, led to significant reductions in combined adverse renal outcomes and in combined adverse cardiovasc...

Novel Drug Slows Progression of Diabetic Kidney Disease
https://www.medscape.com/viewarticle/939724

Oct 22nd, 2020 - For patients with diabetic kidney disease, finerenone, an agent from a new class of selective, nonsteroidal mineralocorticoid receptor antagonists, led to significant reductions in combined adverse renal outcomes and in combined adverse cardiovasc...

Will Mineralocorticoid Receptor Antagonists Move Higher Up the Hypertension Treatment Pathway?
https://www.staging.medscape.com/viewarticle/936725

Sep 3rd, 2020 - Mineralocorticoid receptor antagonists (MRAs) are still finding their place in nephrology. Many of us relegate them to the bottom of our therapeutic bag for use only after we've exhausted other renin-angiotensin-aldosterone (RAAS)-modifying agents...

see more →

Patient Education  1 results see all →